Literature DB >> 22890732

Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1.

Alexander Skorokhod, David Capper, Andreas von Deimling, Alexander Enk, Peter Helmbold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22890732     DOI： 10.1016/j.jaad.2012.03.022

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  19 in total

Review 1.  Molecular pathology of cutaneous melanoma.

Authors:  Léon C van Kempen; Margaret Redpath; Caroline Robert; Alan Spatz
Journal:  Melanoma Manag       Date:  2014-12-04

2.  BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome.

Authors:  Christopher W Toon; Michael D Walsh; Angela Chou; David Capper; Adele Clarkson; Loretta Sioson; Stephen Clarke; Scott Mead; Rhiannon J Walters; Mark Clendenning; Christophe Rosty; Joanne P Young; Aung Ko Win; John L Hopper; Ashley Crook; Andreas von Deimling; Mark A Jenkins; Daniel D Buchanan; Anthony J Gill
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

3.  Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.

Authors:  Michael T Tetzlaff; Penvadee Pattanaprichakul; Jennifer Wargo; Patricia S Fox; Keyur P Patel; Jeannelyn S Estrella; Russell R Broaddus; Michelle D Williams; Michael A Davies; Mark J Routbort; Alexander J Lazar; Scott E Woodman; Wen-Jen Hwu; Jeffrey E Gershenwald; Victor G Prieto; Carlos A Torres-Cabala; Jonathan L Curry
Journal:  Hum Pathol       Date:  2015-05-06       Impact factor: 3.466

4.  Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma Tumors.

Authors:  Erica Riveiro-Falkenbach; Cándida A Villanueva; María C Garrido; Yolanda Ruano; Rosa M García-Martín; Elena Godoy; Pablo L Ortiz-Romero; Juan J Ríos-Martín; Angel Santos-Briz; José L Rodríguez-Peralto
Journal:  J Invest Dermatol       Date:  2015-06-17       Impact factor: 8.551

5.  NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.

Authors:  Arnaud Uguen; Matthieu Talagas; Sebastian Costa; Laura Samaison; Laure Paule; Zarrin Alavi; Marc De Braekeleer; Cédric Le Marechal; Pascale Marcorelles
Journal:  Diagn Pathol       Date:  2015-07-25       Impact factor: 2.644

6.  Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.

Authors:  Michaela Angelika Ihle; Jana Fassunke; Katharina König; Inga Grünewald; Max Schlaak; Nicole Kreuzberg; Lothar Tietze; Hans-Ulrich Schildhaus; Reinhard Büttner; Sabine Merkelbach-Bruse
Journal:  BMC Cancer       Date:  2014-01-10       Impact factor: 4.430

7.  Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600).

Authors:  Alexander Skorokhod; Peter Helmbold; Benedikt Brors; Peter Schirmacher; Alexander Enk; Roland Penzel
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

8.  Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.

Authors:  L Heinzerling; S Kühnapfel; D Meckbach; M Baiter; E Kaempgen; P Keikavoussi; G Schuler; A Agaimy; J Bauer; A Hartmann; F Kiesewetter; R Schneider-Stock
Journal:  Br J Cancer       Date:  2013-04-11       Impact factor: 7.640

9.  Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing.

Authors:  Lucile Boursault; Véronique Haddad; Béatrice Vergier; David Cappellen; Severine Verdon; Jean-Pierre Bellocq; Thomas Jouary; Jean-Philippe Merlio
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

10.  Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma.

Authors:  Michelle V Pearlstein; Daniel C Zedek; David W Ollila; Amanda Treece; Margaret L Gulley; Pamela A Groben; Nancy E Thomas
Journal:  J Cutan Pathol       Date:  2014-07-04       Impact factor: 1.587
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.